MARKET

UPB

UPB

UpStream Bio Inc.
NASDAQ
8.75
-4.05
-31.64%
After Hours: 8.80 +0.05 +0.55% 19:56 02/13 EST
OPEN
12.69
PREV CLOSE
12.80
HIGH
12.69
LOW
8.52
VOLUME
6.50M
TURNOVER
--
52 WEEK HIGH
33.68
52 WEEK LOW
5.14
MARKET CAP
472.84M
P/E (TTM)
-3.8009
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at UPB last week (0209-0213)?
Weekly Report · 17h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 3d ago
Upstream Bio's Selloff May Be 'Overdone,' But Analyst Highlights Asthma Drug's Competitive Edge Concerns
Benzinga · 3d ago
Evercore ISI Remains a Buy on Upstream Bio, Inc. (UPB)
TipRanks · 3d ago
Assessing Upstream Bio (UPB) Valuation After Recent Share Price Volatility
Simply Wall St · 4d ago
Upstream Bio: Hold Rating As Verekitug Faces Competition Among Latest Asthma Data
Seeking Alpha · 4d ago
Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB)
TipRanks · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac
Reuters · 5d ago
More
About UPB
Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist in clinical development, that targets the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. It has advanced this highly potent monoclonal antibody into separate phase II trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and plans to initiate development in chronic obstructive pulmonary disease. TSLP is a member of a class of epithelial cytokines, also including IL-25 and IL-33, commonly referred to as alarmins. TSLP is primarily produced by epithelial cells, especially in the lung, gastrointestinal tract and skin.

Webull offers UpStream Bio Inc. stock information, including NASDAQ: UPB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UPB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UPB stock methods without spending real money on the virtual paper trading platform.